Cardiogenics appears to have turned the readers of this board into skeptics; perhaps we should join Michael Shermer's organization (www.skeptic.com).

IMO until Cardiogenics announces

1.) the status/results of the head-to-head study, and

2.) a financing event to provide funds to enable the company to remain a going concern(PIPE?)

I do not think the share price and daily trade volume will be of any interest to current and future share holders.

Ante